Sign in

CIK 0001752828

  • Emerging growth company

Celularity Inc

Sign in to watch
Ticker
CELU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831702591
Phone
+1 908-768-2170
Business address
170 PARK AVE, FLORHAM PARK, NJ, 07932
Former names
GX Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-06-14 Smith Robin L Director Grant or award +199,921 236,066
2023-06-14 Smith Robin L Director Grant or award · Stock Option (Right to Buy) +277,778 277,778
2022-08-16 Smith Robin L Director Grant or award · Stock Option (Right to Buy) +250,000 250,000
2022-08-16 Smith Robin L Director Grant or award · Stock Option (Right to Buy) +800,000 800,000
2022-07-13 Smith Robin L Director Grant or award +36,145 36,145
2022-07-13 Smith Robin L Director Grant or award · Stock Option (Right to Buy) +54,152 54,152
2021-09-09 Smith Robin L Director Grant or award · Stock Option (Right to Buy) +56,053 56,053
2021-07-16 Smith Robin L Director Grant or award · Stock Option (Right to Buy) +384,297 384,297
2021-07-16 Smith Robin L Director Grant or award · Deferred Compensation Award (Right to Buy) +269,007 269,007

Page 1 of 1 · 9 trades